Vir Biotechnology, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
VIR Company Description
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
VIR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view VIR Smart Score
Score Breakdown
VIR Company Description
Show More
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of VIR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by VIR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on VIR's company Twitter account
WallStreetBets
Number of mentions of VIR in WallStreetBets Daily Discussion
VIR News
Recent insights relating to VIR
CNBC Recommendations
Recent picks made for VIR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in VIR
Corporate Flights
Flights by private jets registered to VIR
Our Analysis